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Abstract
Background: Consumer wrist-worn wearable activity monitors are widely available, low cost and are able to
provide a direct measurement of several markers of physical activity. Despite this, there is limited data on their use
in perioperative risk prediction. We explored whether these wearables could accurately approximate metrics
(anaerobic threshold, peak oxygen uptake and peak work) derived using formalised cardiopulmonary exercise
testing (CPET) in patients undergoing high-risk surgery.
Methods: Patients scheduled for major elective intra-abdominal surgery and undergoing CPET were included.
Physical activity levels were estimated through direct measures (step count, floors climbed and total distance
travelled) obtained through continuous wear of a wrist worn activity monitor (Garmin Vivosmart HR+) for 7 days
prior to surgery and self-report through completion of the short International Physical Activity Questionnaire (IPAQ).
Correlations and receiver operating characteristic (ROC) curve analysis explored the relationships between
parameters provided by CPET and physical activity.
Device selection: Our choice of consumer wearable device was made to maximise feasibility outcomes for this
study. The Garmin Vivosmart HR+ had the longest battery life and best waterproof characteristics of the available
low-cost devices.
Results: Of 55 patients invited to participate, 49 (mean age 65.3 ± 13.6 years; 32 males) were enrolled; 37 provided
complete wearable data for analyses and 36 patients provided full IPAQ data.
Floors climbed, total steps and total travelled as measured by the wearable device all showed moderate correlation
with CPET parameters of peak oxygen uptake (peak VO2) (R = 0.57 (CI 0.29–0.76), R = 0.59 (CI 0.31–0.77) and R =
0.62 (CI 0.35–0.79) respectively), anaerobic threshold (R = 0.37 (CI 0.01–0.64), R = 0.39 (CI 0.04–0.66) and R = 0.42 (CI
0.07–0.68) respectively) and peak work (R = 0.56 (CI 0.27–0.75), R = 0.48 (CI 0.17–0.70) and R = 0.50 (CI 0.2–0.72)
respectively).
Receiver operator curve (ROC) analysis for direct and self-reported measures of 7-day physical activity could
accurately approximate the ventilatory equivalent for carbon dioxide (VE/VCO2) and the anaerobic threshold. The
area under these curves was 0.89 for VE/VCO2 and 0.91 for the anaerobic threshold. For peak VO2 and peak work,
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models fitted using just the wearable data were 0.93 for peak VO2 and 1.00 for peak work.
Conclusions: Data recorded by the wearable device was able to consistently approximate CPET results, both with
and without the addition of patient reported activity measures via IPAQ scores. This highlights the potential utility
of wearable devices in formal assessment of physical functioning and suggests they could play a larger role in pre-
operative risk assessment.
Ethics: This study entitled “uSing wearable TEchnology to Predict perioperative high-riSk patient outcomes (STEPS)”
gained favourable ethical opinion on 24 January 2017 from the Welsh Research Ethics Committee 3 reference
number 17/WA/0006. It was registered on ClinicalTrials.gov with identifier NCT03328039.
Keywords: Cardiopulmonary exercise testing, VO2, Anaerobic threshold, Perioperative medicine, Wearable
technology
Background
Cardiopulmonary exercise testing (CPET) is a non-invasive
clinical tool that allows evaluation of exercise capacity by
global assessment of cardiorespiratory function. Using mea-
sures of respiratory oxygen uptake (VO2), carbon dioxide
production (VCO2) and ventilatory measures, it enables ob-
jective evaluation of both submaximal and peak exercise re-
sponses (Wu et al. 2017). CPET is routinely used to
measure functional capacity in patients prior to major sur-
gery in order to aid clinical decision-making regarding a pa-
tient’s suitability for surgery and inform risk assessment.
Information obtained from CPET can be used to estimate
the likelihood of perioperative morbidity and mortality, to
direct preoperative interventions and optimisation, guide
decisions regarding perioperative management and inform
choice of post-operative care (ward vs. critical care) (Levett
et al. 2018). There is increasing interest in the use of con-
sumer wearable devices to approximate physical activity pa-
rameters for use in the healthcare setting.
However, CPET is expensive and requires a trained
operator, specialist equipment and a significant time
investment from both medical staff and the patient,
which limit its availability for routine use. In
addition, there are several absolute contraindications
to CPET, including many cardiac and respiratory
conditions, that may result in some patients being
ineligible for testing (Albouaini et al. 2007). Some
patients may not be able to perform CPET or
achieve a maximal CPET due to frailty or arthritic
joints. Nosocomial infection, especially currently with
COVID-19, is another reason where encouraging
community access to testing may be preferable.
While the inability to perform CPET does indeed
provide information, it provides it in a binary for-
mat, which conveys less statistical information that
the more graded response achievable from a wear-
able, which meets individuals where they are.
The use of consumer wrist-worn wearable activity
monitors is increasing due to their widespread avail-
ability, decreasing cost and improving accuracy
(Rochmis and Blackburn 1971). These continuously-
evolving technologies are able to provide direct meas-
urement of several markers of physical activity and
their growing popularity highlights the need to fur-
ther evaluate their utility in the healthcare setting.
These devices are able to directly record large
amounts of activity data without a physician present
and represent a possible alternative to CPET that is
more accessible, more affordable and may better rep-
resent a patient’s day-to-day functional capacity.
The aim of this study (uSing wearable TEchnology
to Predict perioperative high-riSk patient outcomes
(STEPS)) was to assess the feasibility of collecting ac-
tivity and physiological data of sufficient quantity and
quality using wrist-worn activity monitors. We then
further explored the relationship between the data




Patients scheduled for major elective intra-abdominal
surgery at the University Hospital of Wales between
June 2017 and February 2018 were included in the study.
Inclusion criteria included: aged 18 years or older, cap-
acity to consent and a clinical indication for planned
CPET before elective major surgery. Exclusion criteria
included atrial fibrillation, nickel allergy, unable to wear
a watch, unable to undergo CPET and pregnancy. Base-
line information on age, gender and body mass index
(BMI) were recorded. Information about the study was
sent by post along with the CPET appointment. Patients
had a discussion about the study on the day of attending
their CPET appointment and consent taken prior to
their test.
Our original sample size was chosen pragmatically to
be 100. This would have allowed the estimation of any
feasibility proportion to within at least plus or minus 9.8
percentage points using a 95% confidence interval.
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CPET
Preoperative CPET was conducted and interpreted by a
consultant anaesthetist experienced in CPET in accord-
ance with national guidelines (Levett et al. 2018) using
an electromagnetically braked cycle ergometer (Lode,
Gronigen, The Netherlands) and a Medgraphics Ultima
metabolic cart (MedGraphics, Gloucester, UK). Calibra-
tion was undertaken in accordance with manufacturer's
guidelines using a 3-L syringe (Hans Rudolph, Kansas
City, KS, USA) and reference calibration gases. During
data collection, the middle five of seven breaths were av-
eraged. An exercise protocol was used whereby patients
cycled at 60 rpm. for 3 min in an unloaded freewheeling
state, followed by a progressively ramped period of exer-
cise (from 5 to 15 W min−1 based on mass, stature, age,
and sex) to volitional or symptom-limited termination,
followed by 3 min recovery. Medgraphics Breeze soft-
ware automatically determined peak oxygen uptake
(VO2peak; defined as the highest O2 uptake during the
final 30 s of exercise reported). The AT was manually
interpreted using the V-slope method (Beaver, Wasser-
men, and Whipp, 1986) and supported by comparison of
end-tidal oxygen tension (ETO2) and ventilatory equiva-
lent for oxygen (VE/VO2) plots. The ventilatory equiva-
lent for carbon dioxide (VE/VCO2 ) was identified at the
AT or was recorded as the gradient of the linear VE/
VCO2 relationship if the AT could not be identified.
AT was not recorded if AT was not reached during
the test or the respiratory exchange ratio (RER) was per-
sistently > 1.0 during the exercise test precluding the de-
termination of AT.
Study outcomes
All participants underwent CPET as part of their routine
pre-operative workup. Four key CPET measures of activ-
ity were recorded: peak oxygen consumption (peak
VO2), the ventilatory equivalent for carbon dioxide (VE/
VCO2 slope), the anaerobic threshold (AT) and peak
work (also known as peak power output). The following
thresholds were used: 14 ml/kg/min was used for the
peak VO2 threshold, 34 ml/min for the VE/VCO2 slope
and 11 ml/kg/min for the anaerobic threshold (Mück
et al. 2019). A median split was used to divide recorded
peak work values.
In addition to this, all participants wore a wearable de-
vice continuously for 7 days prior to their surgery. The
wearable device used was the Garmin Vivosmart HR+
smart activity tracker. A participant information leaflet
was sent to all eligible patients one week prior to attend-
ing a routine CPET clinic. The devices were then issued
to participants after they had completed their CPET as-
sessment. The devices were worn continuously for the
7-day study duration and were then removed and stored
until return during the next routine clinic appointment.
Patients were given clear advice regarding wearing the
device and issued with a charger in case of power failure,
although the battery of the device was sufficient for 7
days of continuous use. The device recorded resting
heart rate, average heart rate, maximum heart rate, total
steps, floors climbed, number of intense minutes of exer-
cise, total calories and total distance travelled. These
variables were averaged across the 7-day period prior to
analysis.
After the 7 days, participants completed the
International Physical Activity Questionnaire (IPAQ)
which identified the metabolic equivalent task (MET)
minutes achieved in different domains (work, transporta-
tion, domestic, garden, leisure time) by self-report.
The total MET minutes of physical activity per week
was computed by summing the MET minutes from each
category (walking, moderate or vigorous activity).
The total time per week in each category was then
multiplied by a constant depending on the level of inten-
sity of the exercise: 3.3 for walking, 4.0 for moderate-
intensity activity and 8.0 for vigorous-intensity activity.
Once the MET minutes per week for each category were
computed, these were summed to produce the total
physical activity MET-minutes/week and the IPAQ glo-
bal score; the patients were then categorised as having a
high, moderate or low level of physical activity.
Statistical analysis
Descriptive data is presented as mean ± standard devi-
ation. Statistical modelling was used to explore the rela-
tionship between parameters provided by CPET, self-
reported activities via the IPAQ and activity measure-
ments recorded by the wearable device.
Graphical exploration of the wearable data was
performed, alongside range checks.
Incomplete data capture was possibly due to sub-
optimal fit of the device or movement of the device on
the wrist during capture, with the device documentation
suggesting that a issues such as sweat, lotion or sun-
screen on the wrist, fit of device (location on the wrist
and tightness of the strap) and intensity of the activity
can contribute to limitations of data capture. In the
future, these issues could be address by repeated checks
to ensure correct fit and care of the device at all times
and continued patient education on optimal use of the
device.
Correlations between variables were calculated using
Pearson correlation coefficients. With Pearson correl-
ation assumptions met, via scatter plots demonstrating
linear covariation and visual inspection of Q-Q plots.
Linear regression was used to explore whether the eight
wearable variables could be used to estimate values for
the four CPET measures of activity. In addition, further
analysis explored whether the addition of IPAQ global
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scores could improve this estimation. Three models
were fitted for each of the four measures of CPET
activity, with all including basic demographic variables
(age, gender, BMI). The first model used only the eight
wearable values as predictors, the second used only the
global IPAQ score and the third model used both of
these components together.
The models were compared using the Akaike Informa-
tion Criteria (AIC). Standard model diagnostics were
explored to ensure adequate model fit, including fitted
versus residual plots. Models were assessed and com-
pared using appropriate statistics, including R2 and
adjusted R2 values, the percentage of correct predictions
and Pearson correlation coefficients (with associated
95% confidence intervals) between the fitted and
observed values. Receiver operator characteristic (ROC)
curves for these models were also compared.
Results
Of 55 invited to participate, 49 (mean age 65 ± 13.6
years, 17 females) were included in the study. All partici-
pants (n = 49) underwent CPET prior to surgery but
only 40 participants had values recorded for their anaer-
obic threshold. Only 36 participants completed the
IPAQ. All wearable devices were returned; there was no
damage noted in any of the devices and no reported is-
sues with the devices during the study but of the 49 de-
vices returned, 12 demonstrated incomplete data capture
and were excluded from analysis. This was not due to
device removal but rather failure of the device to record
data at some timepoints. Correlations between CPET,
wearable and IPAQ variables were only calculated for in-
dividuals who had complete data for each variable re-
quired in the analysis.
Mean (SD) VO2 max was 18.2 ± 4.5 ml/kg/min, VE/VCO2
31.7 ± 4.5, peak work 105.9 ± 39.2 W and anaerobic thresh-
old 11.7 ± 2.4 ml/kg/min. Mean 7-day step count was 6040
± 3323 steps/day and average heart rate was 64 ± 6.8 bpm.
With regard to mean ± SD self-reported MET
minutes, 41.7% proportion of the study sample cate-
gorised as high physical activity (MET total 6898 ±
2847), 30.6% moderate (1739 ± 516) and 27.8% low
physical activity (519 ± 565).
Floors climbed, total number of steps and total
distance travelled (derived from number of steps) as
recorded by the wearable device were most correlated
with the CPET parameters (Table 1, Fig. 1). Floors
climbed, total steps and total distance travelled all
showed moderate correlation with peak VO2 (R = 0.57,
R = 0.59 and R = 0.62 respectively), anaerobic threshold
(R = 0.37, R = 0.39 and R = 0.42 respectively) and peak
work (R = 0.56, R = 0.48 and R = 0.50 respectively).
These three wearable parameters were also significantly
correlated with IPAQ global scores.
A slower average heart rate and resting heart rate were
associated with improved anaerobic threshold (R = −
0.47 and R = − 0.36) and peak VO2 (R = − 0.27 and R =
− 0.26). None of the wearable variables were strongly
correlated with VE/VO2. There were no strong correla-
tions observed between intense minutes of activity,
maximum recorded heart rate or total calories burned
with any of the CPET parameters. Of note, the average,
resting and maximum heart rate variables had small
standard deviations relative to their mean values. These
small standard deviations may partially explain why the
correlations between the heart rate variables and the
CPET measures were weaker than expected.
All correlations between the wearable measures, CPET
parameters and IPAQ global scores are shown in Table 1
and depicted graphically in Fig. 1.
As shown in Table 2, using all eight of the wearable
variables together in linear regression gave a stronger
correlation between the measured CPET values, specific-
ally for peak VO2, anaerobic threshold and peak work
values. For all three models, the model fit was less accur-
ate when estimating the VE/VCO2 slope than for the
Table 1 Pearson correlation coefficients, and 95% confidence intervals, between the measured values for the four CPET scores and
the IPAQ global score, and the eight wearable variables
Wearable variable CPET variables IPAQ global score
Peak VO2 VE/VCO2 AT Peak work
Floors climbed 0.57 (0.29, 0.76) − 0.30 (− 0.58, 0.04) 0.37 (0.01, 0.64) 0.56 (0.27, 0.75) 0.71 (0.45, 0.86)
Intense minutes 0.08 (− 0.26, 0.41) 0.06 (− 0.29, 0.39) − 0.01 (− 0.37, 0.35) 0.06 (− 0.28, 0.39) 0.32 (− 0.07, 0.63)
Average heart rate − 0.27 (− 0.55, 0.08) − 0.01 (− 0.35, 0.33) − 0.47 (− 0.71, − 0.13) − 0.18 (− 0.49, 0.17) − 0.16 (− 0.51, 0.24)
Resting heart rate − 0.26 (− 0.55, 0.08) 0.07 (− 0.28, 0.40) − 0.36 (− 0.64, 0.00) − 0.15 (− 0.46, 0.20) − 0.09 (− 0.46, 0.30)
Maximum heart rate 0.00 (− 0.34, 0.34) − 0.09 (− 0.42, 0.25) − 0.18 (− 0.50, 0.20) 0.16 (− 0.19, 0.47) 0.31 (− 0.08, 0.62)
Total steps 0.59 (0.31, 0.77) − 0.19 (− 0.50, 0.16) 0.39 (0.04, 0.66) 0.48 (0.17, 0.70) 0.54 (0.20, 0.76)
Total calories 0.02 (− 0.32, 0.36) − 0.07 (− 0.40, 0.27) − 0.15 (− 0.48, 0.22) 0.07 (− 0.27, 0.40) 0.20 (− 0.20, 0.54)
Total distance 0.62 (0.35, 0.79) − 0.21 (− 0.51, 0.14) 0.42 (0.07, 0.68) 0.50 (0.20, 0.72) 0.51 (0.17, 0.75)
AT Anaerobic threshold, CPET Cardio-pulmonary exercise testing, VO2 Maximal oxygen uptake, IPAQ International Patient Activity Questionnaire
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other three measures. However, the AIC values of these
models cannot be directly compared as each model
includes different parameters and slight variations in
sample size. When comparing the R2 values, model diag-
nostics demonstrated that the model using both the
wearable data and the IPAQ global score together was
better in estimating CPET scores for all four of the
CPET measures (Table 2).
Receiver operator curve (ROC) analysis demon-
strated that the model using both the wearable data
and the IPAQ scores was the most accurate in
approximating VE/VCO2 and the anaerobic threshold
(Fig. 2). The area under these curves was 0.89 for
VE/VCO2 and 0.91 for the anaerobic threshold. For
peak VO2 and peak work, the ROC curves suggest
that the models fitted using just the wearable data
were a better classification, with the area under
these curves 0.93 for peak VO2 and 1.00 for peak
work. Nonetheless, linear regression using the wear-
able variables and the IPAQ global score independ-
ently, were also able to successfully estimate the
CPET scores in isolation.
Fig. 1 Pearson correlation coefficients between the CPET parameters and the wearable parameters. CPET parameters are peak work, VE/VCO2,
VO2, AT (anaerobic threshold). Wearable parameters are floors climbed, intense minutes of activity, average heart rate, resting heart rate,
maximum heart rate, step count, total calories and total distance
Table 2 Model fit diagnostics for numerous linear models estimating values for the four CPET measures of activity
CPET variable Predictor Sample size Number of parameters AIC R2 R2 adjusted % correct Pearson correlation (95% CI)
Peak VO2 Wearable 34 11 181.62 0.74 0.62 91.18 0.86 (0.74, 0.93)
IPAQ 27 4 163.98 0.29 0.16 77.78 0.54 (0.20, 0.76)
Both 27 12 150.89 0.76 0.55 88.89 0.87 (0.73, 0.94)
VE/VCO2 Wearable 34 11 219.98 0.26 − 0.11 79.41 0.51 (0.20, 0.72)
IPAQ 27 4 172.54 0.19 0.05 85.19 0.44 (0.07, 0.70)
Both 27 12 179.75 0.41 − 0.08 85.19 0.65 (0.35, 0.82)
Anaerobic threshold Wearable 30 11 129.78 0.72 0.56 70 0.85 (0.71, 0.93)
IPAQ 23 4 106.71 0.41 0.27 65.22 0.64 (0.30, 0.83)
Both 23 12 89.91 0.86 0.69 78.29 0.93 (0.83, 0.97)
Peak work Wearable 34 11 328.30 0.73 0.59 100 0.85 (0.72, 0.92)
IPAQ 27 4 271.35 0.44 0.34 85.19 0.66 (0.38, 0.83)
Both 27 12 257.24 0.82 0.66 81.48 0.90 (0.80, 0.96)
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Missing values
Although there was a relatively high proportion of miss-
ing data across the dataset, the correlations of wearable
data with CPET values remained robust perhaps attrib-
uted to the frequency of data sampling despite missing
data.
We have also analysed the results for the 9 patients
missing AT and the 5 of these with missing wearable
data. There were no statistical significant differences
when this analysis is included.
There was a trend towards lower cardiorespiratory fit-
ness in the no-AT group. There was lower Peak VO2,
higher VE/VCO2, lower peak work from which you
might infer lower cardiorespiratory fitness, but the num-
bers are likely too small for statistical analysis.
Discussion
Wearable activity monitors are becoming increasingly
popular amongst consumers due to their decreasing
cost and increasing accessibility (Mück et al. 2019).
The market for wearable devices is experiencing
rapid growth year on year, with worldwide wearable
devices forecasted to increase from 593 million
devices globally in 2018 to 929 million devices by
2021, rising to over 1 billion devices by 2022
(Mancini et al. 1991). However, there remains a
paucity of data around the role of these wearable
devices in the healthcare setting, despite their great
potential to improve upon efficiency, cost and
patient experience.
In this study, we found that data collection using this
novel method to be feasible in terms of logistical and
data capture considerations. We also found a significant
correlation between wearable device measurements of
step count, floors climbed and total travelled as mea-
sured by a Garmin Vivosmart HR+ wearable device and
CPET parameters of anaerobic threshold, peak VO2 and
peak work. In addition, the data recorded by the wear-
able device was consistently associated with CPET
results, both with and without the addition of patient
reported activity measures via IPAQ scores. There will
be times where an IPAQ will be preferred especially with
individuals who struggle with the technological aspects
of wearable devices.
Fig. 2 Receiver operator curve (ROC) analysis curves for the four CPET measures of activity
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Limitations
No data was recorded regarding concomitant medica-
tions that patients may have been taking prior to their
surgery. This is particularly relevant with regard to beta-
blockers, which are commonly given to patients to man-
age arrhythmias and decrease heart rate. This may partly
explain why only low correlations were found between
the maximum heart rate as recorded by the wearable
device and the CPET measures.
In line with recommended practice (cite Lancaster,
Dodd and Williamson), we highlight that the results of
our hypothesis testing should be regarded as exploratory
and therefore interpreted with caution, as no formal
power calculations have been carried out for them.
Data for each recorded parameter was extracted
directly from each device. Of note, raw data captured by
the device was likely cleaned and possibly adjusted by
algorithms in the Garmin software prior to being made
available for extraction; however, specific details of this
process are not available as the software is proprietary.
No further manipulation of the data was performed by
the authors following extraction with the extracted
numerical values for each parameter used directly in
analysis as stated in the “Methods” section.
These results also only apply to the specific wearable
device tested and variation between models and further
developments in the wearable technology may limit the
ability to extrapolate this data accurately to all wearable
devices. However, we feel the main findings are likely to
remain the same as the core technology between models
is similar and these findings still provide key descriptive
evidence on which to base further studies.
Additional limitations of wearable devices include con-
cerns regarding the accuracy of the parameters they
record. In addition, there are large variations in quality
and accuracy of recording accuracy between different
makes and models of wearable device (Forecast 2019).
With regard to utilisation of these devices in the health-
care setting, it would be important to identify reliable
and evidence-based models of device and to ensure the
devices were used correctly by patients and the data re-
corded was accurate. Including a debrief with the pa-
tients when the device data is available may be added to
ensure correct usage and hence data. However, we feel
these represent areas where caution must be taken dur-
ing the integration of wearables in the medical setting,
rather than insurmountable issues, and highlight the
need for further studies to build a better understanding
of this growing field. In addition, many devices use proc-
essed versions of the raw data and changes in these in-
ternal algorithms may impact upon future analysis. The
cost of wearable devices must also be considered and
weighed up against the expense of CPET, although evi-
dence suggests that wearable technologies are continuing
to decrease in cost (Shcherbina et al. 2017). Formal
feasibilities studies will be needed to conclude that the
continued use of wearable technology in a medical
setting is appropriate.
The future
With continuously improving technology, most smart
wrist-worn devices are now not only a chronograph but
are also able to monitor a wide variety of activity param-
eters and personal analytics, including several heart rate
parameters, exercise frequency and activity intensity, as
well as recording sleep parameters and heart rate vari-
ability. The market for these devices is currently increas-
ing exponentially with their improving aesthetics,
decreasing cost, further miniaturisation of components,
improving battery life, and increasing number of features
offered (Mück et al. 2019). As the distinction between
consumer health wearables and medical devices becomes
more fluid, it is important to continue to evaluate their
potential benefits in the healthcare setting and explore
areas in which they can be best utilised as assets to
improve upon existing systems and workflows.
In light of the expense, clinical expertise required, pur-
chase and maintenance of specialist equipment and con-
traindications for CPET, these findings highlight the
potential utility of wearable devices as part of the pre-
operative assessment of functional capacity prior to
major surgery. CPET can be time and labour intensive
for both the patient and the medical staff who conduct
the testing, as well as taking the patient into an artificial
setting in order to push them to their maximal exercise
limits. Wearable devices are able to integrate smoothly
into a patient’s existing routine and may provide a more
accurate representation of a patient’s day-to-day func-
tion within their own environment, so long as there are
worn correctly. We envisage the use of wearable devices
as a more widely accessible screening tool that could be
used to better target CPET resources and further
improve preoperative assessment.
Studies suggest that anaerobic threshold predicts post-
operative complications and mortality, so the consistent
correlation of anaerobic threshold with the majority of
the wearable measures we analysed adds further weight
to the potential of the wearable data to inform upon
post-surgical outcomes (Canhoto and Arp 2017).
VE/VCO2 (the ventilatory equivalent for carbon diox-
ide) was shown to correlate less well with wearable pa-
rameters and IPAQ scores. This measure is the ratio of
minute ventilation to CO2 output, providing information
on ventilation efficiency in the lungs.
We feel a much larger study is warranted to explore if
the correlations can be strengthened with a larger
sample size. These studies would focus on the device
measures that correlate best with CPET metrics in a
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high-risk surgery patient cohort where patient-centred
outcome measures could be assessed.
Conclusions
We have shown that it is possible to utilise wearable
devices to approximate CPET metrics. Further studies
are required to continue to evaluate the potential of
wearable devices in the healthcare setting, and to
further explore how these systems can be accommo-
dated into existing practices to improve upon
efficiency and patient care.
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